Zai Lab Limited (ZLAB)
(Delayed Data from NSDQ)
$15.91 USD
+0.17 (1.08%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $15.94 +0.03 (0.19%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth F Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
ZLAB 15.91 +0.17(1.08%)
Will ZLAB be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for ZLAB based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ZLAB
What Makes Zai Lab Limited Unsponsored ADR (ZLAB) a New Buy Stock
Ultragenyx (RARE) Surges 10.3%: Is This an Indication of Further Gains?
ZLAB: What are Zacks experts saying now?
Zacks Private Portfolio Services
Seagen's (SGEN) Late-Stage Cervical Cancer Study Meets Goals
Zai Lab (ZLAB) Up on Breakthrough Therapy Tag for Oncology Drug
Mirati (MRTX) Q1 Earnings & Revenues Beat Estimates, Stock Up
Other News for ZLAB
ClearBridge Global Growth Strategy Q1 2024 Portfolio Manager Commentary
Baron New Asia Fund Q1 2024 Shareholder Letter
Baron Emerging Markets Fund Q1 2024 Shareholder Letter
ClearBridge International Growth ACWI Ex-US Strategy Q1 2024 Commentary
Zai Lab files automatic ordinary shares offering